CNS5:Diffuse leptomeningeal glioneuronal tumour: Difference between revisions
| [checked revision] | [checked revision] |
Bailey.Glen (talk | contribs) No edit summary |
Bailey.Glen (talk | contribs) No edit summary |
||
| Line 75: | Line 75: | ||
|- | |- | ||
|''NTRK1/2/3'' | |''NTRK1/2/3'' | ||
|Fusion partner not specified (PMID: 29766299) | |Fusion partner not specified (PMID: 29766299) | ||
|Downstream activation of MAPK/ERK signalling pathway in CNS tumors | |Downstream activation of MAPK/ERK signalling pathway in CNS tumors | ||
|Not specified | |Not specified | ||
| Line 83: | Line 83: | ||
|3 cases with ''NTRK1/2/3'' fusions<ref>{{Cite journal|last=Deng|first=Maximilian Y.|last2=Sill|first2=Martin|last3=Chiang|first3=Jason|last4=Schittenhelm|first4=Jens|last5=Ebinger|first5=Martin|last6=Schuhmann|first6=Martin U.|last7=Monoranu|first7=Camelia-Maria|last8=Milde|first8=Till|last9=Wittmann|first9=Andrea|date=2018-08|title=Molecularly defined diffuse leptomeningeal glioneuronal tumor (DLGNT) comprises two subgroups with distinct clinical and genetic features|url=https://pubmed.ncbi.nlm.nih.gov/29766299|journal=Acta Neuropathologica|volume=136|issue=2|pages=239–253|doi=10.1007/s00401-018-1865-4|issn=1432-0533|pmid=29766299}}</ref> | |3 cases with ''NTRK1/2/3'' fusions<ref>{{Cite journal|last=Deng|first=Maximilian Y.|last2=Sill|first2=Martin|last3=Chiang|first3=Jason|last4=Schittenhelm|first4=Jens|last5=Ebinger|first5=Martin|last6=Schuhmann|first6=Martin U.|last7=Monoranu|first7=Camelia-Maria|last8=Milde|first8=Till|last9=Wittmann|first9=Andrea|date=2018-08|title=Molecularly defined diffuse leptomeningeal glioneuronal tumor (DLGNT) comprises two subgroups with distinct clinical and genetic features|url=https://pubmed.ncbi.nlm.nih.gov/29766299|journal=Acta Neuropathologica|volume=136|issue=2|pages=239–253|doi=10.1007/s00401-018-1865-4|issn=1432-0533|pmid=29766299}}</ref> | ||
|- | |- | ||
|''RAF1'' | |''RAF1'' | ||
|''TRIM33:RAF1'' | |''TRIM33:RAF1'' | ||
|Downstream activation of MAPK/ERK signalling pathway in CNS tumors | |Downstream activation of MAPK/ERK signalling pathway in CNS tumors | ||
|t(1;3)(p13;p25) | |t(1;3)(p13;p25) | ||